Monday, 24 May 2021

PRO/AH/EDR> Zika virus (03): Americas, Africa, research, observations

Zika virus -- Worldwide/Unknown
FDA requires blood establishments to test blood donations for new or emerging infectious agents that may affect blood product safety if certain conditions outlined in FDA regulations are met. Specifically, if a transfusion-transmitted infection "may have sufficient incidence and/or prevalence to affect the potential donor population" and meets certain other criteria described in FDA's regulations, then FDA may determine the transfusion-transmitted infection is a "relevant

Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8379378&promed&0

No comments:

Post a Comment